Christoph Kapitza

Board Member at Profil

Dr. Kapitza has over 20 years of diabetes research experience in the development of drugs, devices and drug-device combination products. He has consulted in the clinical development plans (phase 1 through to post-marketing studies) of several new therapeutic entities. Dr. Kapitza has particular interest and expertise in the field of incretin hormones.

Org chart

Oliver Klein

Scientific Study Advisor

Susanne Famulla

Scientific Study Advisor

Lutz Heinemann

Board Member

Ulrike Hövelmann

Scientific Study Advisor

Timeline

  • Board Member

    Current role